Synthesis and evaluation of stimulatory properties of Sphingomonadaceae glycolipids

Nature Chemical Biology

Volumn 3, Issue 9, 2007, Pages 559-564

  Long, Xiangtian ^a   Deng, Shenglou ^a   Mattner, Jochen ^b   Zang, Zhuo ^a   Zhou, Dapeng ^c   McNary, Nathan ^a   Goff, Randal D ^a   Teyton, Luc ^d   Bendelac, Albert ^b   Savage, Paul B ^a  

^a Brigham Young University   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 O (ALPHA GALACTOPYRANOSYL) 2 HEXACOSANOYLAMINO 1,3,4 OCTADECANETRIOL; CERAMIDE; CERAMIDE OLIGOGLYCOSIDE; CERAMIDE TETRAGLYCOSIDE; DIGLYCOSYLCERAMIDE; GLYCOSPHINGOLIPID; IMMUNOSTIMULATING AGENT; MONOGLYCOSYLCERAMIDE; PBS 57; TRIGLYCOSYLCERAMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LYSOSOME; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; SPHINGOMONADACEAE;

SPHINGOMONADACEAE;

EID: 34548057573     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.2007.19     Document Type: Article

References (30)

1. Miller, S.I., Ernst, R.K. & Bader, M.W. LPS, TLR4 and infectious disease diversity. Nat. Rev. Microbiol. 3, 36-46 (2005).
2. Kawahara, K., Kuraishi, H. & Zähringer, U. Chemical structure and function of glycosphingolipids of Sphingomonas spp. and their distribution among members of the α-4 subclass of Proteobacteria. J. Ind. Microbiol. Biotechnol. 23, 408-413 (1999).
3. Amano, K. et al. Deficiency of peptidoglycan and lipopolysaccharide components in Rickettsia tsutsugamushi. Infect. Immun. 55, 2290-2292 (1987).
4. Lin, M. & Rikihisa, Y. Ehrlichia chaffeensis and Anaplasma phagocytophilum lack genes for lipid A biosynthesis and incorporate cholesterol for their survival. Infect. Immun. 71, 5324-5331 (2003).
5. Naka, T. et al. A novel sphingoglycolipid containing galacturonic acid and 2-hydroxy fatty acid in cellular lipids of Sphingomonas yanoikuyae. J. Bacteriol. 182, 2660-2663 (2000).
6. Selmi, C. et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 38, 1250-1257 (2003).
7. Mattner, J. et al. Both exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434, 525-528 (2005).
8. Kinjo, Y. et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434, 520-525 (2005).
9. Sriram, V., Du, W., Gervay-Hague, J. & Brutkiewicz, R.R. Cell wall glycosphingolipids from Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur. J. Immunol. 35, 1692-1701 (2005).
10. Bendelac, A., Savage, P.B. & Teyton, L. Biology of NKT cells. Annu. Rev. Immunol. 25, 297-336 (2007).
11. Yu, K.O.A. & Porcelli, S.A. The diverse functions of CD1d-restricted NKT cells and their potential for immunotherapy. Immunol. Lett. 100, 42-55 (2005).
12. Van Kaer, L. α-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nat. Rev. Immunol. 5, 31-42 (2005).
13. Morita, M. et al. Structure-activity relationship of α-galactosylceramides against B16-bearing mice. J. Med. Chem. 38, 2176-2187 (1995).
14. Fischer, K. et al. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc. Natl. Acad. Sci. USA 101, 10685-10690 (2004).
15. Zhou, D. et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 303, 523-527 (2004).
16. Kinjo, Y. et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat. Immunol. 7, 978-986 (2006).
17. Savage, P.B., Bendelac, A. & Teyton, L. Glycolipids for natural killer T cells. Chem. Soc. Rev. 35, 771-779 (2006).
18. Prigozy, T.I. et al. Glycolipid antigen processing for presentation by CD1d molecules. Science 291, 664-667 (2001).
19. Zhou, X.T. et al. Synthesis and NKT cell stimulating properties of fluorophore- and biotin-appended 6″-amino-6″-deoxy- galactosylceramides. Org. Lett. 4, 1267-1270 (2002).
20. Andersson, F., Fuegedi, P., Garegg, P. & Nashed, M. Synthesis of 1,2-cis-linked glycosides using dimethy(methylthio)sulfonium triflate as promoter and thioglycosides as glycosyl donors. Tetrahedr. Lett. 27, 3919-3922 (1986).
21. Garcia, B.A., Poole, J.L. & Gin, D.Y. Direct glycosylations with 1-hydroxy glycosyl donors using trifluoromethanesulfonic anhydride and diphenyl sulfoxide. J. Am. Chem. Soc. 119, 7597-7598 (1997).
22. Schmidt, R.R. & Michael, J. Einfache synthese von α- und β-O-glycosylimidaten. Herstellung von glykosiden und disacchariden. Angew. Chem. Int. Edn. Engl. 19, 731-732 (1980).
23. Lee, P.T., Benlagha, K., Teyton, L. & Bendelac, A. Distinct functional lineages of human Vα-24 natural killer T cells. J. Exp. Med. 195, 637-641 (2002).
24. Liu, Y. et al. A modified α-galactosyl ceramide for staining and stimulating natural killer T cells. J. Immunol. Methods 312, 34-39 (2006).
25. Roces, D.P. et al. Efficacy of enzyme replacement therapy in α-mannosidosis mice: a preclinical animal study. Hum. Mol. Genet. 13, 1979-1988 (2004).
26. Lusis, A.J. & Paigen, K. Properties of mouse α-galactosidase. Biochim. Biophys. Acta 437, 487-497 (1976).
27. Meikle, P.J., Whittle, A.M. & Hopwood, J.J. Human acetyl-coenzyme A: α-glucosaminide N-acetyltransferase: kinetic characterization and mechanistic interpretation. Biochem. J. 308, 327-333 (1995).
28. Zhou, D. et al. Editing of Cd1-bound lipid antigens by endosomal lipid transfer proteins. Science 303, 523-527 (2004).
29. Sagiv, Y. et al. Cutting edge: impaired glycosphingolipids trafficking and NKT cell development in mice lacking Niemann-Pick type C1 protein. J. Immunol. 177, 26-30 (2006).
30. Zhao, H.G., Li, H.H., Bach, G., Schmidtchen, A. & Neufeld, E.F. The molecular basis of Sanfilippo syndrome type B. Proc. Natl. Acad. Sci. USA 93, 6101-6105 (1996).